Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Curis Announces Positive Data in Ongoing Study of Fimepinostat, Venetoclax Combo

americanpharmaceuticalreviewDecember 12, 2019

Tag: Curis , Fimepinostat , Venetoclax

PharmaSources Customer Service